Pulmonary toxicity. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Lung Macrophages, Alveolar Pulmonary Alveoli Neutrophils Liver Cells, Cultured Cell Line, Tumor Kidney Cell Line Bone Marrow Neurons

Organisms9

Rats, Sprague-Dawley Rats, Inbred F344 Daphnia Mice, Inbred C57BL Bacillus thuringiensis Rats, Wistar Mice, Inbred BALB C Artemia Larva

Diseases51

Lung Diseases Lung Diseases, Interstitial Pulmonary Fibrosis Granuloma, Foreign-Body Pneumonia Lung Neoplasms Alveolitis, Extrinsic Allergic Hodgkin Disease Dyspnea Pulmonary Edema Granuloma Carcinoma, Non-Small-Cell Lung Testicular Neoplasms Neoplasms Leukopenia Drug-Related Side Effects and Adverse Reactions Radiation Injuries Drug-Induced Liver Injury Neutropenia Hematologic Diseases Thrombocytopenia Nausea Neurotoxicity Syndromes Body Weight Neoplasm Metastasis Plant Poisoning Neoplasm Recurrence, Local Stomatitis Breast Neoplasms Adenocarcinoma Abnormalities, Drug-Induced Vomiting Drug Eruptions Disease Models, Animal Gastrointestinal Diseases Drug Overdose Poisoning Mucositis Colorectal Neoplasms Disease Progression Exanthema Head and Neck Neoplasms Ovarian Neoplasms Prostatic Neoplasms Radiodermatitis Brain Neoplasms Male Urogenital Diseases Lymphoma, Non-Hodgkin Kidney Diseases Necrosis Melanoma

Chemicals and Drugs95

Amiodarone Bleomycin Nanotubes, Carbon Tin Compounds Silicon Dioxide Deoxycytidine Skatole Carmustine Hydroxyproline Vinblastine Indium Aluminum Oxide Anti-Arrhythmia Agents Vincristine Antimetabolites, Antineoplastic Aerosols Doxorubicin Cisplatin Procarbazine Quartz Etoposide L-Lactate Dehydrogenase Cyclophosphamide Mucin-1 Paclitaxel Antineoplastic Agents Methotrexate Prednisone Dacarbazine Taxoids Fluorouracil Antineoplastic Agents, Phytogenic Antidotes Camptothecin Carboplatin Teratogens Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Environmental Pollutants Glutathione Insecticides Antineoplastic Agents, Alkylating Plant Extracts Antibiotics, Antineoplastic Antibodies, Monoclonal Acetaminophen Prodrugs Ifosfamide Cadmium Methylmercury Compounds Aluminum Cytochrome P-450 CYP2E1 Neurotoxins Dihydrouracil Dehydrogenase (NADP)Drug Carriers Bacterial Toxins Amyloid beta-Peptides Recombinant Proteins Antioxidants Antibodies, Monoclonal, Humanized Reactive Oxygen Species Topotecan Amifostine Melphalan Herbicides Immunotoxins Xenobiotics Endotoxins Cytarabine Tetrachlorodibenzodioxin Enzyme Inhibitors Liposomes Toxins, Biological Epirubicin Drug Combinations Organophosphorus Compounds Quinazolines Thiazoles Superoxide Dismutase Ethylene Glycols Paraquat Yttrium Radioisotopes Selenium Compounds Hazardous Substances Niacinamide Radiation-Sensitizing Agents Mitomycin Peptides Metals, Heavy Mercury Lead Neuroprotective Agents Polyethylene Glycols Carcinogens

Analytical, Diagnostic and Therapeutic Techniques and Equipment64

Instillation, Drug Antineoplastic Combined Chemotherapy Protocols Bronchoalveolar Lavage Fluid Toxicity Tests Combined Modality Therapy Drug Administration Schedule Intubation, Intratracheal Fatal Outcome Administration, Inhalation Treatment Outcome Toxicity Tests, Acute Radiotherapy Dosage Tomography, X-Ray Computed Thoracic Surgery, Video-Assisted Respiratory Function Tests Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Neoplasm Staging Lethal Dose 50 Prospective Studies Toxicity Tests, Chronic Infusions, Intravenous No-Observed-Adverse-Effect Level Maximum Tolerated Dose Administration, Oral Drug Evaluation Toxicity Tests, Subchronic Drug Evaluation, Preclinical Animal Testing Alternatives Radiotherapy Organ Size Toxicity Tests, Subacute Dose Fractionation Body Weight Radiotherapy, Conformal Area Under Curve Remission Induction Injections, Intravenous Salvage Therapy Radioimmunotherapy Clinical Trials, Phase I as Topic Drug Carriers Radiotherapy, Intensity-Modulated Disease Models, Animal Follow-Up Studies Drug Delivery Systems Drug Overdose Feasibility Studies Chemotherapy, Adjuvant Mutagenicity Tests Hematologic Tests Injections, Intraperitoneal Clinical Trials as Topic Metabolic Clearance Rate Chemoradiotherapy Dose-Response Relationship, Radiation Drug Therapy, Combination Blood Cell Count Carcinogenicity Tests Models, Biological Biological Assay Injections, Subcutaneous

Phenomena and Processes29

Particle Size Dose-Response Relationship, Drug Time Factors Lethal Dose 50 No-Observed-Adverse-Effect Level Cell Survival Maximum Tolerated Dose Drug Interactions Organ Size Body Weight Area Under Curve Oxidative Stress Apoptosis Tissue Distribution Drug Synergism Cell Death Biotransformation Metabolic Detoxication, Drug Drug Resistance, Neoplasm Mutation Molecular Structure Structure-Activity Relationship Metabolic Clearance Rate Dose-Response Relationship, Radiation Blood Cell Count Half-Life Cytoprotection Necrosis Larva

Disciplines and Occupations2

Toxicology Toxicogenetics

Technology, Industry, Agriculture6

Nanotubes, Carbon Household Products Nanoparticles Metal Nanoparticles Liposomes Polyethylene Glycols

Information Science4

Fatal Outcome Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care16

Inhalation Exposure Fatal Outcome Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Prospective Studies Radiation Injuries Area Under Curve Clinical Trials, Phase I as Topic Follow-Up Studies Feasibility Studies Clinical Trials as Topic Dose-Response Relationship, Radiation Societies, Scientific

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Instillation, Drug Amiodarone Lung Diseases Lung Bleomycin Inhalation Exposure Nanotubes, Carbon Household Products Lung Diseases, Interstitial Pulmonary Fibrosis Tin Compounds Particle Size Silicon Dioxide Antineoplastic Combined Chemotherapy Protocols Granuloma, Foreign-Body Bronchoalveolar Lavage Fluid Deoxycytidine Skatole Toxicity Tests Carmustine Hydroxyproline Vinblastine Indium Pneumonia Aluminum Oxide Anti-Arrhythmia Agents Lung Neoplasms Alveolitis, Extrinsic Allergic Vincristine Antimetabolites, Antineoplastic Combined Modality Therapy Aerosols Doxorubicin Dose-Response Relationship, Drug Cisplatin Drug Administration Schedule Intubation, Intratracheal Procarbazine Quartz Etoposide Hodgkin Disease L-Lactate Dehydrogenase Cyclophosphamide Dyspnea Mucin-1 Fatal Outcome Administration, Inhalation Pulmonary Edema Treatment Outcome Granuloma Toxicity Tests, Acute Radiotherapy Dosage Paclitaxel Antineoplastic Agents Methotrexate Prednisone Carcinoma, Non-Small-Cell Lung Dacarbazine Macrophages, Alveolar Taxoids Pulmonary Alveoli Time Factors Testicular Neoplasms Tomography, X-Ray Computed Thoracic Surgery, Video-Assisted Neoplasms Respiratory Function Tests Disease-Free Survival Rats, Sprague-Dawley Survival Rate Survival Analysis Retrospective Studies Neoplasm Staging Neutrophils Lethal Dose 50 Prospective Studies Toxicity Tests, Chronic Infusions, Intravenous No-Observed-Adverse-Effect Level Fluorouracil Cell Survival Maximum Tolerated Dose Administration, Oral Toxicology Drug Evaluation Leukopenia Antineoplastic Agents, Phytogenic Drug-Related Side Effects and Adverse Reactions Radiation Injuries Drug-Induced Liver Injury Liver Neutropenia Toxicity Tests, Subchronic Antidotes Camptothecin Carboplatin Hematologic Diseases Teratogens Drug Evaluation, Preclinical Organoplatinum Compounds

No FAQ available that match "pulmonary toxicity"